Trial Information

Summary: Seroquel in Dysphoric Hypomania

A Double-Blind, Placebo-Controlled Trial of Seroquel for the Treatment of Dysphoric Hypomania in Bipolar II Patients, Stanford University Bipolar Disorders Clinic.

We are examining the use of quetiapine (Seroquel) in the treatment of patients currently experiencing both hypomania and depressive symptoms (dysphoric hypomania). In this study, after an initial evaluation phase, patients will be instructed to add Seroquel or a placebo to their current stable medication regimen for a period of eight weeks while being monitored by a psychiatrist using clinical and laboratory measures.

For more information,

Contact:

Kristine L. Keller, B.S.C.
Stanford University School of Medicine
Bipolar Disorders Clinic
Department of Psychiatry and Behavioral Sciences
401 Quarry Road, Room 2131
Stanford, CA 94305-5723
Telephone: 650-498-4968
Fax: 650-723-2507
Email:

Profile Page: Stanford University School of Medicine, Stanford, CA

  

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:03 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA